share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Feb 26 23:30
Summary by Futu AI
Vertex Pharmaceuticals Inc. officer, Sanna Bastiano, is set to sell 4,239 shares of common stock on 02/26/2024, with an aggregate market value of approximately $1,804,542. The shares to be sold were recently acquired on 02/24/2024, with 2,120 shares obtained through restricted stock vesting and 2,119 shares through performance shares, both as part of compensation from the issuer. This planned sale follows a three-month period where a total of 10,149 shares were sold by the officer, generating gross proceeds of around $4,266,460.
Vertex Pharmaceuticals Inc. officer, Sanna Bastiano, is set to sell 4,239 shares of common stock on 02/26/2024, with an aggregate market value of approximately $1,804,542. The shares to be sold were recently acquired on 02/24/2024, with 2,120 shares obtained through restricted stock vesting and 2,119 shares through performance shares, both as part of compensation from the issuer. This planned sale follows a three-month period where a total of 10,149 shares were sold by the officer, generating gross proceeds of around $4,266,460.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.